Goldman Sachs’s Sinovac Biotech, Ltd SVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-11,668
| Closed | -$79K | – | 4623 |
|
|
2017
Q2 | $79K | Buy |
+11,668
| New | +$79K | ﹤0.01% | 4183 |
|
|
2016
Q1 | – | Sell |
-13,727
| Closed | -$79K | – | 4829 |
|
|
2015
Q4 | $79K | Buy |
13,727
+728
| +6% | +$4.19K | ﹤0.01% | 4054 |
|
|
2015
Q3 | $66K | Sell |
12,999
-22,203
| -63% | -$113K | ﹤0.01% | 4273 |
|
|
2015
Q2 | $185K | Sell |
35,202
-56,026
| -61% | -$294K | ﹤0.01% | 4048 |
|
|
2015
Q1 | $452K | Sell |
91,228
-38,895
| -30% | -$193K | ﹤0.01% | 3382 |
|
|
2014
Q4 | $681K | Sell |
130,123
-32,091
| -20% | -$168K | ﹤0.01% | 3164 |
|
|
2014
Q3 | $780K | Sell |
162,214
-4,589
| -3% | -$22.1K | ﹤0.01% | 3054 |
|
|
2014
Q2 | $941K | Buy |
166,803
+155,215
| +1,339% | +$876K | ﹤0.01% | 3001 |
|
|
2014
Q1 | $83K | Buy |
+11,588
| New | +$83K | ﹤0.01% | 4166 |
|